Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[IGHV mutational statue in patients with splenic marginal zone lymphoma].
Yang WJ, Yu Z, Lyu R, Li ZJ, Li H, Xiong WJ, Yi SH, Liu W, Qiu LG. Yang WJ, et al. Among authors: qiu lg. Zhonghua Xue Ye Xue Za Zhi. 2016 Sep 14;37(9):774-778. doi: 10.3760/cma.j.issn.0253-2727.2016.09.009. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27719720 Free PMC article. Chinese.
[Long-term follow-up of multiple myeloma after autologous hematopoietic stem cell transplantation: a single center results].
Sui WW, Zou DH, An G, Yi SH, Deng SH, Huang WY, Wang TY, Li J, Liu H, Fu MW, Lyu R, Liu W, Xu Y, Li ZJ, Zhao YZ, Qiu LG. Sui WW, et al. Among authors: qiu lg. Zhonghua Xue Ye Xue Za Zhi. 2017 Jun 14;38(6):499-504. doi: 10.3760/cma.j.issn.0253-2727.2017.06.007. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28655093 Free PMC article. Chinese.
[Dose-adjusted EPOCH/EDOCH plus rituximab in untreated double-protein expression lymphoma].
Liu W, Li J, Huang WY, Liu H, Li ZJ, Lv R, Deng SH, Fu MW, Sui WW, Wang TY, Qiu LG, Zou DH. Liu W, et al. Among authors: qiu lg. Zhonghua Xue Ye Xue Za Zhi. 2017 Jun 14;38(6):548-551. doi: 10.3760/cma.j.issn.0253-2727.2017.06.017. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28655103 Free PMC article. Chinese. No abstract available.
[Tolerance and pharmacodynamics phase Ⅰ clinical trial study of chimeric anti-CD20 monoclonal antibody IBI301 in Chinese patients with CD20-positive non-Hodgkin's lymphoma].
Jiang B, Qi JY, Sun MY, Li ZJ, Liu W, Liu LJ, Zhang FK, Qiu LG. Jiang B, et al. Among authors: qiu lg. Zhonghua Xue Ye Xue Za Zhi. 2018 Apr 14;39(4):320-324. doi: 10.3760/cma.j.issn.0253-2727.2018.04.013. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 29779330 Free PMC article. Clinical Trial. Chinese.
6,331 results